Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Arrhythmias

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 190 articles:
HTML format
Text format



Single Articles


    September 2017
  1. NICHOL G, Sayre MR, Guerra F, Poole J, et al
    Defibrillation for Ventricular Fibrillation: A Shocking Update.
    J Am Coll Cardiol. 2017;70:1496-1509.
    PubMed     Text format     Abstract available


  2. PASTORI D, Nocella C, Farcomeni A, Bartimoccia S, et al
    Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1455-1462.
    PubMed     Text format     Abstract available


  3. BLOOMGARDEN ZT, Kosiborod MN, Handelsman Y
    Concomitant Diabetes and Atrial Fibrillation: No Sugarcoating the Bittersweet Reality.
    J Am Coll Cardiol. 2017;70:1336-1338.
    PubMed     Text format    


  4. ECHOUFFO-TCHEUGUI JB, Shrader P, Thomas L, Gersh BJ, et al
    Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.
    J Am Coll Cardiol. 2017;70:1325-1335.
    PubMed     Text format     Abstract available


  5. NAZARIAN S, Zghaib T
    Is Atrial Fibrillation a Necessary Component of the Thrombogenic Atrium?
    J Am Coll Cardiol. 2017;70:1322-1324.
    PubMed     Text format    


  6. KING JB, Azadani PN, Suksaranjit P, Bress AP, et al
    Left Atrial Fibrosis and Risk of Cerebrovascular and Cardiovascular Events in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1311-1321.
    PubMed     Text format     Abstract available


  7. ESCANDE W, Boveda S, Defaye P, Leclercq C, et al
    Outcomes in Guideline-Based Versus Off-Guideline Primary Prevention Implantable Cardioverter-Defibrillator Recipients.
    J Am Coll Cardiol. 2017;70:1302-1303.
    PubMed     Text format    


    August 2017
  8. DESIMONE CV, Graff-Radford J, El-Harasis MA, Rabinstein AA, et al
    Cerebral Amyloid Angiopathy: Diagnosis, Clinical Implications, and Management Strategies in Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1173-1182.
    PubMed     Text format     Abstract available


  9. YANNOPOULOS D, Bartos JA, Raveendran G, Conterato M, et al
    Coronary Artery Disease in Patients With Out-of-Hospital Refractory Ventricular Fibrillation Cardiac Arrest.
    J Am Coll Cardiol. 2017;70:1109-1117.
    PubMed     Text format     Abstract available


  10. WAZNI O, Chung MK
    Catheter Ablation for Rate Controlled Atrial Fibrillation: New Horizon in Heart Failure Treatment.
    J Am Coll Cardiol. 2017 Aug 22. pii: S0735-1097(17)39348.
    PubMed     Text format    


  11. PRABHU S, Taylor AJ, Costello BT, Kaye DM, et al
    Catheter Ablation Versus Medical Rate control in Atrial Fibrillation and Systolic Dysfunction (CAMERA-MRI).
    J Am Coll Cardiol. 2017 Aug 22. pii: S0735-1097(17)39349.
    PubMed     Text format     Abstract available


  12. SILKA MJ, Bar-Cohen Y
    Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease: Sequel or Series?
    J Am Coll Cardiol. 2017;70:866-868.
    PubMed     Text format    


  13. LABOMBARDA F, Hamilton R, Shohoudi A, Aboulhosn J, et al
    Increasing Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease.
    J Am Coll Cardiol. 2017;70:857-865.
    PubMed     Text format     Abstract available


  14. POOLE JE, Prutkin JM
    Subcutaneous Implantable Cardioverter-Defibrillator Finding a Place in Sudden Cardiac Death Prevention: Emerging or Emerged?
    J Am Coll Cardiol. 2017;70:842-844.
    PubMed     Text format    


  15. BOERSMA L, Barr C, Knops R, Theuns D, et al
    Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.
    J Am Coll Cardiol. 2017;70:830-841.
    PubMed     Text format     Abstract available


  16. IWASAWA J, Koruth JS, Petru J, Dujka L, et al
    Temperature-Controlled Radiofrequency Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:542-553.
    PubMed     Text format     Abstract available


    July 2017
  17. SCHWARTZ PJ, Dagradi F, Castelletti S
    Evolution in Managing Long QT Syndrome: From Registries to Centers of Excellence.
    J Am Coll Cardiol. 2017;70:463-465.
    PubMed     Text format    


  18. ROHATGI RK, Sugrue A, Bos JM, Cannon BC, et al
    Contemporary Outcomes in Patients With Long QT Syndrome.
    J Am Coll Cardiol. 2017;70:453-462.
    PubMed     Text format     Abstract available


  19. SEKI A, Ishikawa T, Daumy X, Mishima H, et al
    Progressive Atrial Conduction Defects Associated With Bone Malformation Caused by a Connexin-45 Mutation.
    J Am Coll Cardiol. 2017;70:358-370.
    PubMed     Text format     Abstract available


  20. WHANG W
    Opportunities to Improve Outcomes in Atrial Fibrillation: Provider Specialty and Beyond.
    J Am Coll Cardiol. 2017;70:87-88.
    PubMed     Text format    


  21. PERINO AC, Fan J, Schmitt SK, Askari M, et al
    Treating Specialty and Outcomes in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
    J Am Coll Cardiol. 2017;70:78-86.
    PubMed     Text format     Abstract available


    June 2017
  22. MILLER MA, Palaniswamy C, Dukkipati SR, Balulad S, et al
    Subcutaneous Implantable Cardioverter-Defibrillator Implantation Without Defibrillation Testing.
    J Am Coll Cardiol. 2017;69:3118-3119.
    PubMed     Text format    


  23. VASEGHI M, Barwad P, Malavassi Corrales FJ, Tandri H, et al
    Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias.
    J Am Coll Cardiol. 2017;69:3070-3080.
    PubMed     Text format     Abstract available


  24. VIJAYARAMAN P, Bordachar P, Ellenbogen KA
    The Continued Search for Physiological Pacing: Where Are We Now?
    J Am Coll Cardiol. 2017;69:3099-3114.
    PubMed     Text format     Abstract available


  25. HALPERIN JL
    Preventing Myocardial Infarction in Patients With Atrial Fibrillation: Another Piece of the Puzzle.
    J Am Coll Cardiol. 2017;69:2910-2912.
    PubMed     Text format    


  26. LEE CJ, Pallisgaard JL, Olesen JB, Carlson N, et al
    Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2901-2909.
    PubMed     Text format     Abstract available


  27. FILIPPATOS G, Farmakis D
    How to Use Beta-Blockers in Heart Failure With Reduced Ejection Fraction and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2897-2900.
    PubMed     Text format    


  28. YAO X, Shah ND, Sangaralingham LR, Gersh BJ, et al
    Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
    J Am Coll Cardiol. 2017;69:2779-2790.
    PubMed     Text format     Abstract available


    May 2017
  29. SOLOMON SD, Chatterjee NA
    Who Benefits From Implantable Cardioverter-Defibrillators?: Integrating Absolute, Proportional, and Competing Risk.
    J Am Coll Cardiol. 2017;69:2619-2621.
    PubMed     Text format    


  30. BILCHICK KC, Wang Y, Cheng A, Curtis JP, et al
    Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.
    J Am Coll Cardiol. 2017;69:2606-2618.
    PubMed     Text format     Abstract available


  31. O'KEEFE JH, DiNicolantonio JJ
    Alcohol and Atrial Fibrillation: Mitigating the Risk.
    J Am Coll Cardiol. 2017;69:2578.
    PubMed     Text format    


  32. NATTEL S
    Atrial Fibrillation and Body Composition: Is it Fat or Lean That Ultimately Determines the Risk?
    J Am Coll Cardiol. 2017;69:2498-2501.
    PubMed     Text format    


  33. FENGER-GRON M, Overvad K, Tjonneland A, Frost L, et al
    Lean Body Mass Is the Predominant Anthropometric Risk Factor for Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2488-2497.
    PubMed     Text format     Abstract available


  34. PETERSON ED, Pokorney SD
    New Treatment Options Fail to Close the Anticoagulation Gap in Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2485-2487.
    PubMed     Text format    


  35. MARZEC LN, Wang J, Shah ND, Chan PS, et al
    Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2475-2484.
    PubMed     Text format     Abstract available


  36. DORKS M, Jobski K, Herget-Rosenthal S, Hoffmann F, et al
    Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.
    J Am Coll Cardiol. 2017;69:2471.
    PubMed     Text format    


  37. CHAN YH, Kuo CT
    Reply: Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.
    J Am Coll Cardiol. 2017;69:2471-2472.
    PubMed     Text format    


  38. MUELLER KAL, Heinzmann D, Klingel K, Fallier-Becker P, et al
    Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy.
    J Am Coll Cardiol. 2017;69:2160-2172.
    PubMed     Text format     Abstract available


  39. SANTANGELI P, Frankel DS, Tung R, Vaseghi M, et al
    Early Mortality After Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease.
    J Am Coll Cardiol. 2017;69:2105-2115.
    PubMed     Text format     Abstract available


    April 2017
  40. HUCKER WJ, Hanley A, Ellinor PT
    Improving Atrial Fibrillation Therapy: Is There a Gene for That?
    J Am Coll Cardiol. 2017;69:2088-2095.
    PubMed     Text format     Abstract available


  41. SUNDARAM V, Sahadevan J, Waldo AL, Stukenborg GJ, et al
    Implantable Cardioverter-Defibrillators With Versus Without Resynchronization Therapy in Patients With a QRS Duration >180 ms.
    J Am Coll Cardiol. 2017;69:2026-2036.
    PubMed     Text format     Abstract available


  42. HOBBELT AH, Spronk HM, Crijns HJ, Ten Cate H, et al
    Prethrombotic State in Young Very Low-Risk Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1990-1992.
    PubMed     Text format    


  43. DU X, Dong J, Ma C
    Is Atrial Fibrillation a Preventable Disease?
    J Am Coll Cardiol. 2017;69:1968-1982.
    PubMed     Text format     Abstract available


  44. LORBERBAUM T, Tatonetti NP
    Reply: Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome and Torsades de Pointes Risk.
    J Am Coll Cardiol. 2017;69:1877-1878.
    PubMed     Text format    


  45. LAZZERINI PE, Bertolozzi I, Rossi M, Capecchi PL, et al
    Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk.
    J Am Coll Cardiol. 2017;69:1876-1877.
    PubMed     Text format    


  46. SANTANGELI P, Rame JE, Birati EY, Marchlinski FE, et al
    Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure.
    J Am Coll Cardiol. 2017;69:1842-1860.
    PubMed     Text format     Abstract available


  47. DRIESSEN AH, Berger WR, Chan Pin Yin DR, Piersma FR, et al
    Electrophysiologically Guided Thoracoscopic Surgery for Advanced Atrial Fibrillation: 5-Year Follow-up.
    J Am Coll Cardiol. 2017;69:1753-1754.
    PubMed     Text format    


  48. FLETCHER G
    Atrial Fibrillation: A Threat to the Failing Heart?
    J Am Coll Cardiol. 2017;69:1692-1693.
    PubMed     Text format    


  49. LUO N, Merrill P, Parikh KS, Whellan DJ, et al
    Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1683-1691.
    PubMed     Text format     Abstract available


    March 2017
  50. BREITHARDT G
    NOACs for Stroke Prevention in Atrial Fibrillation With Valve Disease: Filling the Gaps.
    J Am Coll Cardiol. 2017;69:1383-1385.
    PubMed     Text format    


  51. RENDA G, Ricci F, Giugliano RP, De Caterina R, et al
    Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease.
    J Am Coll Cardiol. 2017;69:1363-1371.
    PubMed     Text format     Abstract available


  52. DE CATERINA R, Renda G, Carnicelli AP, Nordio F, et al
    Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
    J Am Coll Cardiol. 2017;69:1372-1382.
    PubMed     Text format     Abstract available


  53. LIM HS, Hocini M, Dubois R, Denis A, et al
    Complexity and Distribution of Drivers in Relation to Duration of Persistent Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1257-1269.
    PubMed     Text format     Abstract available


  54. MILLER JM, Kalra V, Das MK, Jain R, et al
    Clinical Benefit of Ablating Localized Sources for Human Atrial Fibrillation: The Indiana University FIRM Registry.
    J Am Coll Cardiol. 2017;69:1247-1256.
    PubMed     Text format     Abstract available


  55. ARBUSTINI E, Favalli V, Narula N, Serio A, et al
    Reply: A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic Dilation.
    J Am Coll Cardiol. 2017;69:1210-1211.
    PubMed     Text format    


  56. SCHWEIZER PA, Koenen M, Katus HA, Thomas D, et al
    A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic Dilation.
    J Am Coll Cardiol. 2017;69:1209-1210.
    PubMed     Text format    


    February 2017
  57. SHARMA S, Drezner JA, Baggish A, Papadakis M, et al
    International Recommendations for Electrocardiographic Interpretation in Athletes.
    J Am Coll Cardiol. 2017;69:1057-1075.
    PubMed     Text format     Abstract available


  58. KABRA R, Girotra S, Vaughan Sarrazin M
    Reply: Race and Stroke Risk in Atrial Fibrillation: The Limitations of a Social Construct.
    J Am Coll Cardiol. 2017;69:907-908.
    PubMed     Text format    


  59. JOHNSON AE, Magnani JW
    Race and Stroke Risk in Atrial Fibrillation: The Limitations of a Social Construct.
    J Am Coll Cardiol. 2017;69:906-907.
    PubMed     Text format    


  60. DEEDWANIA P, Acharya T
    Anticoagulation in Atrial Fibrillation: Is the Paradigm Really Shifting?
    J Am Coll Cardiol. 2017;69:786-788.
    PubMed     Text format    


  61. HUISMAN MV, Rothman KJ, Paquette M, Teutsch C, et al
    The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.
    J Am Coll Cardiol. 2017;69:777-785.
    PubMed     Text format     Abstract available


  62. BONDE AN, Lip GY, Kamper AL, Staerk L, et al
    Effect of Reduced Renal Function on Time in Therapeutic Range Among Anticoagulated Atrial Fibrillation Patients.
    J Am Coll Cardiol. 2017;69:752-753.
    PubMed     Text format    


  63. VADUGANATHAN M, Patel RB, Michel A, Shah SJ, et al
    Mode of Death in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;69:556-569.
    PubMed     Text format     Abstract available


  64. VENLET J, Piers SR, Jongbloed JD, Androulakis AF, et al
    Isolated Subepicardial Right Ventricular Outflow Tract Scar in Athletes With Ventricular Tachycardia.
    J Am Coll Cardiol. 2017;69:497-507.
    PubMed     Text format     Abstract available


    January 2017
  65. PICCINI JP, Granger CB
    Insulin Therapy and Stroke Risk in Patients With Diabetes and Atrial Fibrillation: Guilty by Association?
    J Am Coll Cardiol. 2017;69:420-422.
    PubMed     Text format    


  66. PATTI G, Lucerna M, Cavallari I, Ricottini E, et al
    Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF.
    J Am Coll Cardiol. 2017;69:409-419.
    PubMed     Text format     Abstract available


  67. VAL-BLASCO A, Piedras MJ, Ruiz-Hurtado G, Suarez N, et al
    Role of NOD1 in Heart Failure Progression via Regulation of Ca2+ Handling.
    J Am Coll Cardiol. 2017;69:423-433.
    PubMed     Text format     Abstract available


  68. VAUGHAN SARRAZIN MS, Jones M, Mazur A, Cram P, et al
    Cost of Hospital Admissions in Medicare Patients With Atrial Fibrillation Taking Warfarin, Dabigatran, or Rivaroxaban.
    J Am Coll Cardiol. 2017;69:360-362.
    PubMed     Text format    


  69. HUMMEL J
    Substrate Ablation Without Pulmonary Vein Isolation: A Reasonable Proposition for Atrial Fibrillation Ablation?
    J Am Coll Cardiol. 2017;69:322-324.
    PubMed     Text format    


  70. GOLDBERGER JJ, Mitrani RD
    Autonomic Tone and Atrial Fibrillation: A Double-Edged Sword?
    J Am Coll Cardiol. 2017;69:300-302.
    PubMed     Text format    


  71. AGARWAL SK, Norby FL, Whitsel EA, Soliman EZ, et al
    Cardiac Autonomic Dysfunction and Incidence of Atrial Fibrillation: Results From 20 Years Follow-Up.
    J Am Coll Cardiol. 2017;69:291-299.
    PubMed     Text format     Abstract available


  72. BETZ JK, Katz DF, Peterson PN, Borne RT, et al
    Outcomes Among Older Patients Receiving Implantable Cardioverter-Defibrillators for Secondary Prevention: From the NCDR ICD Registry.
    J Am Coll Cardiol. 2017;69:265-274.
    PubMed     Text format     Abstract available


  73. SEITZ J, Bars C, Theodore G, Beurtheret S, et al
    AF Ablation Guided by Spatiotemporal Electrogram Dispersion Without Pulmonary Vein Isolation: A Wholly Patient-Tailored Approach.
    J Am Coll Cardiol. 2017;69:303-321.
    PubMed     Text format     Abstract available


  74. MADHAVAN M, Mulpuru SK, McLeod CJ, Cha YM, et al
    Advances and Future Directions in Cardiac Pacemakers: Part 2 of a 2-Part Series.
    J Am Coll Cardiol. 2017;69:211-235.
    PubMed     Text format     Abstract available


  75. MULPURU SK, Madhavan M, McLeod CJ, Cha YM, et al
    Cardiac Pacemakers: Function, Troubleshooting, and Management: Part 1 of a 2-Part Series.
    J Am Coll Cardiol. 2017;69:189-210.
    PubMed     Text format     Abstract available


  76. DOHERTY JU, Gluckman TJ, Hucker WJ, Januzzi JL Jr, et al
    2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force.
    J Am Coll Cardiol. 2017 Jan 5. pii: S0735-1097(16)37085.
    PubMed     Text format    


    December 2016
  77. VOSKOBOINIK A, Prabhu S, Ling LH, Kalman JM, et al
    Alcohol and Atrial Fibrillation: A Sobering Review.
    J Am Coll Cardiol. 2016;68:2567-2576.
    PubMed     Text format     Abstract available


  78. JAMES CA, Calkins H
    Further Progress in Predicting Life-Threatening Arrhythmias in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    J Am Coll Cardiol. 2016;68:2551-2553.
    PubMed     Text format    


  79. MAZZANTI A, Ng K, Faragli A, Maragna R, et al
    Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.
    J Am Coll Cardiol. 2016;68:2540-2550.
    PubMed     Text format     Abstract available


  80. GOMEZ-OUTES A, Lagunar-Ruiz J, Terleira-Fernandez AI, Calvo-Rojas G, et al
    Causes of Death in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:2508-2521.
    PubMed     Text format     Abstract available


  81. KALMAN JM, Nalliah CJ, Sanders P
    Surgical Weight Loss and Atrial Fibrillation: A Convenient Paradigm to Evaluate a Complex Problem.
    J Am Coll Cardiol. 2016;68:2505-2507.
    PubMed     Text format    


  82. JAMALY S, Carlsson L, Peltonen M, Jacobson P, et al
    Bariatric Surgery and the Risk of New-Onset Atrial Fibrillation in Swedish Obese Subjects.
    J Am Coll Cardiol. 2016;68:2497-2504.
    PubMed     Text format     Abstract available


  83. HSU JC, Maddox TM, Marcus GM
    Reply: Anticoagulation Treatment for Stroke Prevention in Atrial Fibrillation Is Increasing, But Further Improvements Needed.
    J Am Coll Cardiol. 2016;68:2493.
    PubMed     Text format    


  84. BROWN JD, Shewale AR, Dherange P, Talbert JC, et al
    Anticoagulation Treatment for Stroke Prevention in Atrial Fibrillation Is Increasing, But Further Improvements Needed.
    J Am Coll Cardiol. 2016;68:2492.
    PubMed     Text format    


    November 2016
  85. CHAN YH, Yeh YH, See LC, Wang CL, et al
    Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.
    J Am Coll Cardiol. 2016;68:2272-2283.
    PubMed     Text format     Abstract available


  86. KOTECHA D, Lam CS, Van Veldhuisen DJ, Van Gelder IC, et al
    Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins.
    J Am Coll Cardiol. 2016;68:2217-2228.
    PubMed     Text format     Abstract available


  87. MARCHLINSKI FE, Edvardsen T
    Arrhythmogenic Right Ventricular Cardiomyopathy: Better Tools for Detecting Early Disease and Progression.
    J Am Coll Cardiol. 2016;68:2198-2200.
    PubMed     Text format    


  88. MAST TP, Teske AJ, Walmsley J, van der Heijden JF, et al
    Right Ventricular Imaging and Computer Simulation for Electromechanical Substrate Characterization in Arrhythmogenic Right Ventricular Cardiomyopathy.
    J Am Coll Cardiol. 2016;68:2185-2197.
    PubMed     Text format     Abstract available


  89. SEEGER J, Gonska B, Rodewald C, Wolfgang Rottbauer, et al
    TCT-227 Apixaban in patients with atrial fibrillation after transfemoral aortic valve implantation compared with vitamin K antagonist.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  90. FAGGIONI M, Chandrasekhar J, Aquino M, Vogel B, et al
    TCT-224 Real world use of antithrombotic regimens after percutaneous coronary intervention in patients with atrial fibrillation.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  91. DORDI R, Kosmidou I, Redfors B, Dizon J, et al
    TCT-199 Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With STEMI Undergoing Primary PCI: The HORIZONS-AMI Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  92. PATEL N, Patel N, Arora S, Badheka A, et al
    TCT-118 Sex Differences in Coronary Angiography, Percutaneous Coronary Intervention, and Outcomes During Hospitalization After Out of Hospital Cardiac Arrest with Ventricular Fibrillation or Pulseless Ventricular Tachycardia.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  93. HENRY T, Patel A, Schaer G, DeMaria A, et al
    TCT-824 Reduction in Ventricular Arrhythmias with Ixmyelocel-T: Results from the IxCell-DCM Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  94. GHIRARDI G, Ferrari C, Pontone G, Trabattoni D, et al
    TCT-809 Stenting for the treatment of pulmonary vein stenosis after atrial fibrillation radiofrequency catheter ablation: initial experience with peripheral stents plus drug-coated balloons and coronary drug-eluting stents.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  95. KINDSVATER S, Squiers J, Tabachnick D, Brown DL, et al
    TCT-754 New Persistent Left Bundle Branch Block after Transcatheter Aortic Valve Replacement is Associated with High Rate of Mortality.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  96. SANNINO A, Stoler RC, Lima B, Szerlip M, et al
    TCT-648 Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  97. LEE SH, Cho JY, Joo HJ, Park JH, et al
    TCT-620 A comparison of clinical outcomes between triple antithrombotic therapy versus dual antiplatelet with left atrial appendage occlusion in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  98. REDDY V, Akehurst R, Gavaghan M, Amorosi S, et al
    TCT-617 Cost Effectiveness Following Treatment Initiation of Stroke Reduction Strategies in Non-Valvular Atrial Fibrillation: Warfarin vs NOACs vs Left Atrial Appendage Closure.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  99. PARK DW, Kang SH, Choi H, Ahn JM, et al
    TCT-327 Prevalence, Management, and Outcomes of Atrial Fibrillation Among Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  100. FRANCO LN, Sahay S, Rodes-Cabau J, Jimenez P, et al
    TCT-25 Efficacy and Safety of Left Atrial Appendage Closure Versus Medical Treatment in Atrial Fibrillation: A Network Metaanalysis From Randomized Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


    October 2016
  101. REDDY VY, Gibson DN, Kar S, O'Neill W, et al
    Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation.
    J Am Coll Cardiol. 2016 Oct 27. pii: S0735-1097(16)36641.
    PubMed     Text format     Abstract available


  102. GOLLOB MH
    Toward Translation of Genomic Discovery to Clinical Efficacy in Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1895-1897.
    PubMed     Text format    


    September 2016
  103. LAU YC, Proietti M, Guiducci E, Blann AD, et al
    Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease.
    J Am Coll Cardiol. 2016;68:1452-64.
    PubMed     Text format     Abstract available


  104. CHAN YH, Kuo CT, Yeh YH, Chang SH, et al
    Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1389-401.
    PubMed     Text format     Abstract available


  105. GIERULA J, Paton MF, Byrom R, Cubbon RM, et al
    Reply: The Paradox of Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1253.
    PubMed     Text format    


  106. CERIT L
    The Paradox of Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1252-3.
    PubMed     Text format    


  107. ESCANDE W, Marijon E, Defaye P, Piot O, et al
    Electrical Storms in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention.
    J Am Coll Cardiol. 2016;68:1248-50.
    PubMed     Text format    


  108. HYLEK EM, Ko D
    Atrial Fibrillation and Fall Risk: What Are the Treatment Implications?
    J Am Coll Cardiol. 2016;68:1179-80.
    PubMed     Text format    


  109. STEFFEL J, Giugliano RP, Braunwald E, Murphy SA, et al
    Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis.
    J Am Coll Cardiol. 2016;68:1169-78.
    PubMed     Text format     Abstract available


  110. MICHAUD GF, Kumar S
    Surgical Ganglionic Plexus Ablation in Atrial Fibrillation: Is All Hope Lost for the Plexus?
    J Am Coll Cardiol. 2016;68:1166-8.
    PubMed     Text format    


  111. DRIESSEN AH, Berger WR, Krul SP, van den Berg NW, et al
    Ganglion Plexus Ablation in Advanced Atrial Fibrillation: The AFACT Study.
    J Am Coll Cardiol. 2016;68:1155-65.
    PubMed     Text format     Abstract available


  112. TAMAYO SG, Simeone JC, Nordstrom BL, Patel MR, et al
    Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1144-6.
    PubMed     Text format    


    August 2016
  113. CURTIS JP, Akar JG
    A Fresh Perspective on Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:905-7.
    PubMed     Text format    


  114. SUTTON NR, Seth M, Ruwende C, Gurm HS, et al
    Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68:895-904.
    PubMed     Text format     Abstract available


  115. OLDE NORDKAMP LR, Conte G, Rosenmoller BR, Warnaars JL, et al
    Brugada Syndrome and the Subcutaneous Implantable Cardioverter-Defibrillator.
    J Am Coll Cardiol. 2016;68:665-6.
    PubMed     Text format    


  116. GRANGER CB, Thomas KL
    Stroke Prediction in Atrial Fibrillation: Is it Black and White?
    J Am Coll Cardiol. 2016;68:471-2.
    PubMed     Text format    


  117. KABRA R, Girotra S, Vaughan Sarrazin M
    Refining Stroke Prediction in Atrial Fibrillation Patients by Addition of African-American Ethnicity to CHA2DS2-VASc Score.
    J Am Coll Cardiol. 2016;68:461-70.
    PubMed     Text format     Abstract available


    July 2016
  118. YAP SC, Ramjankhan F, Muslem R, de Jonge N, et al
    Ventricular Arrhythmias in Patients With a Continuous-Flow Left Ventricular Assist Device.
    J Am Coll Cardiol. 2016;68:323-5.
    PubMed     Text format    


  119. RAMOS R, Comas-Cufi M, Alves-Cabratosa L, Garcia-Gil M, et al
    Reply: Peripheral Artery Disease and Atrial Fibrillation: The Dangerous Combination.
    J Am Coll Cardiol. 2016;68:238.
    PubMed     Text format    


  120. KESER A, Ozbek K, Katlandur H, Ulucan S, et al
    Peripheral Artery Disease and Atrial Fibrillation: The Dangerous Combination.
    J Am Coll Cardiol. 2016;68:237-8.
    PubMed     Text format    


  121. DHRUVA SS, Redberg RF
    Sex-Specific Data for the Subcutaneous Implantable Cardioverter-Defibrillator.
    J Am Coll Cardiol. 2016;68:133.
    PubMed     Text format    


  122. DEL-CARPIO MUNOZ F, Yao X, Abraham NS, Bellolio MF, et al
    Dabigatran Versus Warfarin in Relation to Renal Function in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:129-31.
    PubMed     Text format    


    June 2016
  123. NOSEWORTHY PA, Yao X, Shah ND, Gersh BJ, et al
    Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation.
    J Am Coll Cardiol. 2016;67:3020-1.
    PubMed     Text format    


  124. DESHPANDE S, Wann LS
    Aspirin in Atrial Fibrillation: The Clot Thickens.
    J Am Coll Cardiol. 2016;67:2924-6.
    PubMed     Text format    


  125. HSU JC, Maddox TM, Kennedy K, Katz DF, et al
    Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke.
    J Am Coll Cardiol. 2016;67:2913-23.
    PubMed     Text format     Abstract available


  126. HEIDENREICH PA, Solis P, Estes NA 3rd, Fonarow GC, et al
    2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
    J Am Coll Cardiol. 2016 Jun 24. pii: S0735-1097(16)32400.
    PubMed     Text format    


  127. HAVAKUK O, Viskin S
    Reply: Long-QT Syndrome, Brugada Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia: A Tale of 3 Diseases : Ibutilide as a Torsade de Pointes Stress Test.
    J Am Coll Cardiol. 2016;67:2806-7.
    PubMed     Text format    


  128. PATANE S
    Long-QT Syndrome, Brugada Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia: A Tale of 3 Diseases.
    J Am Coll Cardiol. 2016;67:2805.
    PubMed     Text format    


  129. VOGLER J, Willems S, Steven D
    Reply: Persistent Atrial Fibrillation: Time to Stop Comparing Apples With Oranges: Atrial Fibrillation: Beyond the Pulmonary Veins.
    J Am Coll Cardiol. 2016;67:2701-2.
    PubMed     Text format    


  130. SCHRICKER AA, Krummen DE, Hsu JC
    Atrial Fibrillation: Beyond the Pulmonary Veins.
    J Am Coll Cardiol. 2016;67:2700-1.
    PubMed     Text format    


  131. PROVIDENCIA R, Lambiase PD
    Persistent Atrial Fibrillation: Time to Stop Comparing Apples With Oranges.
    J Am Coll Cardiol. 2016;67:2699-700.
    PubMed     Text format    


    May 2016
  132. LIAO Z, Zhan X, Wu S, Xue Y, et al
    Reply: Cautionary Pulmonary Insufficiency in Ablation of Ventricular Arrhythmias From Pulmonary Sinus Cusps.
    J Am Coll Cardiol. 2016;67:2562.
    PubMed     Text format    


  133. REN JF, Callans DJ, Marchlinski FE
    Cautionary Pulmonary Insufficiency in Ablation of Ventricular Arrhythmias From Pulmonary Sinus Cusps.
    J Am Coll Cardiol. 2016;67:2560-2.
    PubMed     Text format    


  134. PIAZZA G, Karipineni N, Goldberg HS, Jenkins KL, et al
    Underutilization of Anticoagulation for Stroke Prevention in Atrial Fibrillation.
    J Am Coll Cardiol. 2016;67:2444-6.
    PubMed     Text format    


  135. ASHBURNER JM, Singer DE
    Reply: Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing Evidence.
    J Am Coll Cardiol. 2016;67:2319.
    PubMed     Text format    


  136. OVERVAD TF, Bronnum Nielsen P, Bjerregaard Larsen T
    Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing Evidence.
    J Am Coll Cardiol. 2016;67:2318-9.
    PubMed     Text format    


  137. VAN DEN HAM HA, Klungel OH, Singer DE, Leufkens HG, et al
    Reply: Comparing the ATRIA, CHADS2, and CHA2DS2-VASc Scores for Stroke Prediction in Atrial Fibrillation.
    J Am Coll Cardiol. 2016;67:2317-8.
    PubMed     Text format    


  138. POTPARA TS, Olesen JB
    Comparing the ATRIA, CHADS2, and CHA2DS2-VASc Scores for Stroke Prediction in Atrial Fibrillation.
    J Am Coll Cardiol. 2016;67:2316-7.
    PubMed     Text format    


  139. SINNECKER D, Dommasch M, Steger A, Berkefeld A, et al
    Expiration-Triggered Sinus Arrhythmia Predicts Outcome in Survivors of Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;67:2213-20.
    PubMed     Text format     Abstract available


  140. LIAO Z, Zhan X, Wu S, Xue Y, et al
    Reply: Our Perspective on Ventricular Arrhythmias Originating From Pulmonary Sinus Cusp.
    J Am Coll Cardiol. 2016;67:2196-7.
    PubMed     Text format    


  141. YANG Y, Liu Q, Zhou S, Xiao Y, et al
    Our Perspective on Ventricular Arrhythmias Originating From Pulmonary Sinus Cusp.
    J Am Coll Cardiol. 2016;67:2195-6.
    PubMed     Text format    


  142. SAFDER TB, Badgett RG
    Predicting Stroke in Patients With Atrial Fibrillation: An Incomplete Picture Without Considering Quality of Anticoagulation.
    J Am Coll Cardiol. 2016;67:2192-3.
    PubMed     Text format    


    April 2016
  143. TJONG FV, Brouwer TF, Kooiman KM, Smeding L, et al
    Communicating Antitachycardia Pacing-Enabled Leadless Pacemaker and Subcutaneous Implantable Defibrillator.
    J Am Coll Cardiol. 2016;67:1865-6.
    PubMed     Text format    


  144. VERMOND RA, Geelhoed B, Rienstra M
    Reply: Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation: A Factor Not To Be Disregarded.
    J Am Coll Cardiol. 2016;67:1754-5.
    PubMed     Text format    


  145. ONAT A, Simsek B, Akbas T
    Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation: A Factor Not to Be Disregarded.
    J Am Coll Cardiol. 2016;67:1753-4.
    PubMed     Text format    


  146. ANGUERA I, Garcia-Alberola A, Dallaglio P, Toquero J, et al
    Shock Reduction With Long-Term Quinidine in Patients With Brugada Syndrome and Malignant Ventricular Arrhythmia Episodes.
    J Am Coll Cardiol. 2016;67:1653-4.
    PubMed     Text format    


    March 2016
  147. WILDE AA, Postema PG
    Risk Stratification in Brugada Syndrome: The "Impossible" Made Possible?
    J Am Coll Cardiol. 2016;67:1441-3.
    PubMed     Text format    


  148. CALO L, Giustetto C, Martino A, Sciarra L, et al
    A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I.
    J Am Coll Cardiol. 2016;67:1427-40.
    PubMed     Text format     Abstract available


  149. CHEN LY, Agarwal SK, Norby FL, Gottesman RF, et al
    Persistent but not Paroxysmal Atrial Fibrillation Is Independently Associated With Lower Cognitive Function: ARIC Study.
    J Am Coll Cardiol. 2016;67:1379-80.
    PubMed     Text format    


  150. ELLIOTT AD, Pathak RK, Mahajan R, Lau DH, et al
    Reply: Benefit of Exercise in Atrial Fibrillation: Diastolic Function Matters!
    J Am Coll Cardiol. 2016;67:1258-9.
    PubMed     Text format    


  151. HALLE M, Adams V, Edelmann F, Pieske B, et al
    Benefit of Exercise in Atrial Fibrillation: Diastolic Function Matters!
    J Am Coll Cardiol. 2016;67:1257-8.
    PubMed     Text format    


  152. ARBELO E, Sarquella-Brugada G, Brugada J
    Gene-Specific Therapy for Congenital Long QT Syndrome: Are We There Yet?
    J Am Coll Cardiol. 2016;67:1059-61.
    PubMed     Text format    


  153. MAZZANTI A, Maragna R, Faragli A, Monteforte N, et al
    Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3.
    J Am Coll Cardiol. 2016;67:1053-8.
    PubMed     Text format     Abstract available


  154. POOLE JE, Singh JP, Birgersdotter-Green U
    QRS Duration or QRS Morphology: What Really Matters in Cardiac Resynchronization Therapy?
    J Am Coll Cardiol. 2016;67:1104-17.
    PubMed     Text format     Abstract available


    February 2016
  155. D'AVILA A, Singh SM
    Ventricular Tachycardia Ablation: Are We Winning the Battle But Losing the War?
    J Am Coll Cardiol. 2016;67:684-6.
    PubMed     Text format    


  156. MARCHLINSKI FE, Haffajee CI, Beshai JF, Dickfeld TM, et al
    Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial.
    J Am Coll Cardiol. 2016;67:674-83.
    PubMed     Text format     Abstract available


  157. MERCHANT FM, Quest T, Leon AR, El-Chami MF, et al
    Implantable Cardioverter-Defibrillators at End of Battery Life: Opportunities for Risk (Re)-Stratification in ICD Recipients.
    J Am Coll Cardiol. 2016;67:435-44.
    PubMed     Text format     Abstract available


  158. LEWIS GF, Gold MR
    Safety and Efficacy of the Subcutaneous Implantable Defibrillator.
    J Am Coll Cardiol. 2016;67:445-54.
    PubMed     Text format     Abstract available


    January 2016
  159. KRACHLER B, Lindahl B
    Atrial Fibrillation Is an Obesity-Related Outcome, Requiring a Body Composition-Neutral Assessment of Cardiorespiratory Fitness.
    J Am Coll Cardiol. 2016;67:349.
    PubMed     Text format    


  160. PATHAK RK, Elliott AD, Mahajan R, Lau DH, et al
    Reply: Atrial Fibrillation Is an Obesity-Related Outcome, Requiring a Body Composition-Neutral Assessment of Cardiorespiratory Fitness.
    J Am Coll Cardiol. 2016;67:349-50.
    PubMed     Text format    


  161. GARDIN JM
    The Value of Left Ventricular Relative Wall Thickness in Predicting Ventricular Arrhythmia and Related Death.
    J Am Coll Cardiol. 2016;67:313-5.
    PubMed     Text format    


  162. BITON Y, Goldenberg I, Kutyifa V, Baman JR, et al
    Relative Wall Thickness and the Risk for Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction.
    J Am Coll Cardiol. 2016;67:303-12.
    PubMed     Text format     Abstract available


  163. BLOOMGARDEN Z, Bansilal S
    A Diabetes-Atrial Fibrillation Conundrum: Does Duration Trump Glycemia?
    J Am Coll Cardiol. 2016;67:248-50.
    PubMed     Text format    


  164. PHILIPPART R, Brunet-Bernard A, Clementy N, Bourguignon T, et al
    CHA2DS2-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis.
    J Am Coll Cardiol. 2016;67:343-4.
    PubMed     Text format    


  165. ASHBURNER JM, Go AS, Chang Y, Fang MC, et al
    Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.
    J Am Coll Cardiol. 2016;67:239-47.
    PubMed     Text format     Abstract available


  166. HAVAKUK O, Viskin S
    A Tale of 2 Diseases: The History of Long-QT Syndrome and Brugada Syndrome.
    J Am Coll Cardiol. 2016;67:100-8.
    PubMed     Text format     Abstract available


  167. MASOUDI FA, Calkins H, Kavinsky CJ, Drozda JP Jr, et al
    Reply: Left Atrial Appendage Occlusion Device Societal Overview: The Surgeon's Comment.
    J Am Coll Cardiol. 2016;67:125.
    PubMed     Text format    


  168. EMMERT MY, Salzberg SP
    Left Atrial Appendage Occlusion Device Societal Overview: The Surgeon's Comment.
    J Am Coll Cardiol. 2016;67:124.
    PubMed     Text format    


    December 2015
  169. MILLER JD, Aronis KN, Chrispin J, Patil KD, et al
    Obesity, Exercise, Obstructive Sleep Apnea, and Modifiable Atherosclerotic Cardiovascular Disease Risk Factors in Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:2899-906.
    PubMed     Text format     Abstract available


  170. LIAO Z, Zhan X, Wu S, Xue Y, et al
    Idiopathic Ventricular Arrhythmias Originating From the Pulmonary Sinus Cusp: Prevalence, Electrocardiographic/Electrophysiological Characteristics, and Catheter Ablation.
    J Am Coll Cardiol. 2015;66:2633-2644.
    PubMed     Text format     Abstract available


  171. SHERWOOD MW, Nessel CC, Hellkamp AS, Mahaffey KW, et al
    Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial.
    J Am Coll Cardiol. 2015;66:2271-81.
    PubMed     Text format     Abstract available


  172. LIP GY, Lane DA
    Matching the NOAC to the Patient: Remember the Modifiable Bleeding Risk Factors.
    J Am Coll Cardiol. 2015;66:2282-4.
    PubMed     Text format    


    November 2015
  173. PATHAK RK, Mahajan R, Lau DH, Sanders P, et al
    Reply: BMI Reduction Decreases AF Recurrence Rate in a Mediterranean Cohort.
    J Am Coll Cardiol. 2015;66:2265-6.
    PubMed     Text format    


  174. FIORAVANTI F, Brisinda D, Sorbo AR, Fenici R, et al
    BMI Reduction Decreases AF Recurrence Rate in a Mediterranean Cohort.
    J Am Coll Cardiol. 2015;66:2264-5.
    PubMed     Text format    


  175. VISKIN S, Havakuk O, Schwaber MJ
    Pro-Arrhythmic Effects of Noncardiac Medications: Lessons From Macrolide Antibiotics.
    J Am Coll Cardiol. 2015;66:2185-8.
    PubMed     Text format    


  176. CHENG YJ, Nie XY, Chen XM, Lin XX, et al
    The Role of Macrolide Antibiotics in Increasing Cardiovascular Risk.
    J Am Coll Cardiol. 2015;66:2173-84.
    PubMed     Text format     Abstract available


  177. CAMPUZANO O, Brugada R
    Age, Genetics, and Fibrosis in the Brugada Syndrome.
    J Am Coll Cardiol. 2015;66:1987-9.
    PubMed     Text format    


  178. NADEMANEE K, Raju H, de Noronha SV, Papadakis M, et al
    Fibrosis, Connexin-43, and Conduction Abnormalities in the Brugada Syndrome.
    J Am Coll Cardiol. 2015;66:1976-86.
    PubMed     Text format     Abstract available


    October 2015
  179. PATHAK RK, Mehta AB, Lau DH, Sanders P, et al
    Reply: Going Over LEGACY With a Pinch of Salt.
    J Am Coll Cardiol. 2015;66:1946.
    PubMed     Text format    


  180. VALENTOVA M, Raad N, Anker SD
    Going Over LEGACY With a Pinch of Salt.
    J Am Coll Cardiol. 2015;66:1945.
    PubMed     Text format    


  181. ABRAMOWITZ Y, Jilaihawi H, Chakravarty T, Mack MJ, et al
    Mitral Annulus Calcification.
    J Am Coll Cardiol. 2015;66:1934-41.
    PubMed     Text format     Abstract available


  182. ZIPES DP, Link MS, Ackerman MJ, Kovacs RJ, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiolog
    J Am Coll Cardiol. 2015 Oct 27. pii: S0735-1097(15)06577.
    PubMed     Text format    


  183. LINK MS, Estes NA 3rd, Maron BJ
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    J Am Coll Cardiol. 2015 Oct 27. pii: S0735-1097(15)06582.
    PubMed     Text format    


  184. GOPINATHANNAIR R, Etheridge SP, Marchlinski FE, Spinale FG, et al
    Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management.
    J Am Coll Cardiol. 2015;66:1714-28.
    PubMed     Text format     Abstract available


    September 2015
  185. DUKKIPATI SR, Cuoco F, Kutinsky I, Aryana A, et al
    Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation.
    J Am Coll Cardiol. 2015;66:1350-60.
    PubMed     Text format     Abstract available


  186. MILLER MA, Neuzil P, Dukkipati SR, Reddy VY, et al
    Leadless Cardiac Pacemakers: Back to the Future.
    J Am Coll Cardiol. 2015;66:1179-89.
    PubMed     Text format     Abstract available


  187. NELSON BW, Van Wagoner DR
    How Does Diazoxide Elicit Arrhythmias in Rats With Type 2 Diabetes?: Is This Effect Clinically Significant?
    J Am Coll Cardiol. 2015;66:1157-9.
    PubMed     Text format    


  188. XIE C, Hu J, Motloch LJ, Karam BS, et al
    The Classically Cardioprotective Agent Diazoxide Elicits Arrhythmias in Type 2 Diabetes Mellitus.
    J Am Coll Cardiol. 2015;66:1144-56.
    PubMed     Text format     Abstract available


  189. KOWEY PR, Robinson VM
    Observing the Obvious.
    J Am Coll Cardiol. 2015;66:1008-10.
    PubMed     Text format    


    June 2015
  190. MASOUDI FA, Calkins H, Kavinsky CJ, Drozda JP Jr, et al
    2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview: A Professional Societal Overview from the American College of Cardiology, Heart Rhythm Society, and Society for Cardiovascular Angiography and Interventions.
    J Am Coll Cardiol. 2015 Jun 20. pii: S0735-1097(15)02852.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: